Skip to content

IgA IA3832Recalls & reported problems

Randox Laboratories Limited · The product is intended for the quantitative in vitro determination of IgA in serum or plasma. · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Recalls naming this device

  1. Nov 1, 2022Terminated

    Update to the carryover avoidance technical bulletin to detail that IgA and IgM assays should not be run immediately after Fructosamine Catalogue Number FR3133 or FR4030 on the RX instruments testing order. Can lead to an elevation in Quality Control and Patient results of up to +13% for lgA and +51% for lgM respectively, which may lead to a delay in running patient samples or erroneous elevated test results

    Z-0362-2023 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Other Iga, Antigen, Antiserum, Control devices

All Iga, Antigen, Antiserum, Control devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page